9 Apr 2010 11:33
RNS Number : 9602J
Credit Suisse Securities (Eur) Ltd
09 April 2010
|
FORM 38.5 (a)
|
|
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
|
|
WITH RECOGNISED INTERMEDIARY STATUS
|
|
DEALING IN A CLIENT-SERVING CAPACITY
|
|
(Rule 38.5(a) of the Takeover Code)
AMENDMENT
The amendment in position represents the effect of a late booked trade, book transfer and/or cancel/correct activity
|
|
1. KEY INFORMATION
|
|
Name of exempt principal trader
|
Credit Suisse Securities (Europe) Limited
|
|
Company dealt in
|
Ark Therapeutics Group PLC
|
|
Class of relevant security to which the dealings being disclosed relate (Note 1)
|
Ordinary Shares
|
|
Date of dealing
|
07-Apr-2010
|
|
|
|
|
|
2. DEALINGS (Note 2)
|
|
(a) Purchases and sales
|
|
Total number of securities purchased
|
Highest price paid (Note 3)
|
Lowest price paid (Note 3)
|
|
26766
|
0.0975 (GBP)
|
0.0975 (GBP)
|
|
|
|
|
Total number of securities sold
|
Highest price received (Note 3)
|
Lowest price received (Note 3)
|
|
29548
|
0.0975 (GBP)
|
0.0975 (GBP)
|
|
|
|
|
|
(b) Derivatives transactions (other than options)
|
|
Product name, e.g. CFD
|
Long/short (Note 4)
|
Number of securities (Note 5)
|
Price per unit (Note 3)
|
|
|
|
|
|
|
|
|
|
|
(c) Options transactions in respect of existing securities
|
|
(i) Writing, selling, purchasing or varying
|
|
Product name,e.g. call option
|
Writing, selling, purchasing, varying etc.
|
Number of securities to which the option relates (Note 5)
|
Exercise price
|
Type, e.g. American, European etc.
|
Expiry date
|
Option money paid/received per unit (Note 3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) Exercising
|
|
Product name, e.g. call option
|
Number of securities
|
Exercise price per unit (Note 3)
|
|
|
|
|
|
|
|
|
|
3. OTHER INFORMATION
|
|
Agreements, arrangements or understandings relating to options or derivatives
|
|
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
|
|
|
|
|
|
|
|
Date of disclosure
|
09-Apr-2010
|
|
Contact name
|
Collins, Carolyn/Simon Crawley
|
|
Telephone number
|
0207 888 0241
|
|
Name of offeree/offeror with which connected
|
Ark Therapeutics Group PLC
|
|
Nature of connection (Note 6)
|
ADVISOR
|
|
|
|
|
|
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk.
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMLLFVISLIAIII
Sign In
Follow the stocks
